跳至主要内容
临床试验/ISRCTN15045512
ISRCTN15045512进行中(未招募)Unknown

Varicella zoster recombinant HZ/su vaccine: immunogenicity and safety in people living with HIV according to LTCD4 count strata

niversity of Rome Tor Vergata0 个研究点目标入组 500 人开始时间: 2024年3月5日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. People living with HIV (PLWHIV) =18 years old, on antiretroviral treatment, virally suppressed (HIVRNA <50 copies/ml in the last 6 months)
  • 2. Able to provide informed consent
  • 3. Available CD4 cell count in the last 6 months

排除标准

  • 1. Age <18 years old
  • 2. Active herpes zoster episode at enrollment
  • 3. Acute disease/fever at enrollment
  • 4. Known allergy to vaccine component
  • 5. Other than HIV immunosuppressive condition or treatment. Prednisone <20 mg/day, or equivalent, is allowed. Inhaled and topical steroids are allowed
  • 6. Pregnancy
  • 7. Lactation
  • 8. Women planning to become pregnant or planning to discontinue contraceptive methods

研究者

发起方
niversity of Rome Tor Vergata

相似试验